Clinical Trials Logo

Filter by:
NCT ID: NCT05076773 Completed - Pain, Postoperative Clinical Trials

TPVB, PECSB, ESPB for Postmastectmy Pain

RCT
Start date: April 10, 2019
Phase: N/A
Study type: Interventional

Aim of the work The aim of the study is to compare between the effects of ultrasound guided thoracic paravertebral block, pectoral nerve block II, and erector spinae block in management of pain during cancer breast surgeries. The hypothesis of the study is that the three groups will give comparative results.

NCT ID: NCT05445622 Completed - Healthy Clinical Trials

Assessing Student Learning of Spinal Mobilization With Real-time Objective Feedback

Start date: April 10, 2019
Phase: N/A
Study type: Interventional

This is a research project on physical therapy education. Subjects will be recruited using convenience sampling from second-year physical therapy students on the campus of Youngstown State University. There are currently 28 students in the class. All students will be recruited to participate in the study. The objective of the study is to assess student learning of grades of spinal mobilization with real-time objective feedback.

NCT ID: NCT04087460 Completed - Pneumonia Clinical Trials

Phase Ⅰa Clinical Trial of a Pneumococcal Vaccine

P?CTPV
Start date: April 10, 2020
Phase: Early Phase 1
Study type: Interventional

Infections with Streptococcus pneumoniae often cause serious health problems, especially for infants and the elderly.Failure to cover all polysaccharide types is an even greater problem with adults than with children. The aim of the study is to preliminary evaluate the safety and immunogenicity of PBPV vaccine compared to placebo,in order to provide a basis for subsequent clinical trial design.

NCT ID: NCT04087980 Completed - Prostate Cancer Clinical Trials

Ablation of Prostate Tissue Utilizing Sterile Water Vapor in Patients With Intermediate Risk Localized Prostate Cancer

Start date: April 10, 2020
Phase: N/A
Study type: Interventional

The purpose of this research study is to collect information on a new treatment of prostate tissue participants with intermediate risk prostate cancer using a medical device called the Poseidon System. The Poseidon System is intended to ablate prostate tissue in areas of the prostate where cancer has been identified. The medical device delivers thermal energy in the form of water vapor to the prostate tissue through the urethra. Previous research has shown successful prostate tissue ablation. Additional research may help show successful ablation of the prostate tissue where cancer is located.

NCT ID: NCT04198584 Completed - Chronic Hepatitis C Clinical Trials

Study of Telemedicine Stress Management and Lifestyle Group Intervention for HCV Patients

VC-CBCS
Start date: April 10, 2020
Phase: N/A
Study type: Interventional

A pilot feasibility study of a small randomized controlled trial (RCT) comparing a video-conferencing cognitive behavioral coping skills (VC-CBCS) group to standard of care (SC) for symptomatic patients previously diagnosed with chronic hepatitis C to evaluate feasibility, patient satisfaction and differences in symptoms, quality of life and liver markers.

NCT ID: NCT04243954 Completed - Cancer Pain Clinical Trials

Intravenous vs Oral Analgesia in Cancer Patients With Severe Pain After Successful Titration

Start date: April 10, 2020
Phase: Phase 2
Study type: Interventional

Pain is one of the most common and fear symptoms for cancer patients, which seriously affects the quality of life in cancer patients. At present, oral opioid is the most common route to administrate cancer pain. However, the patients do not satisfy the pain administration with oral opioid after successful titration in many cases, especially the cases with severe cancer pain. Patient controlled analgesia (PCA) with hydromorphone can take analgesic effect rapidly. The aim of this trial is to compare the maintenance with hydromorphone PCA intravenously or switch to Sustained-Release Morphine orally after successful titraton with hydromorphone PCA intravenously in severe cancer pain.

NCT ID: NCT04244097 Completed - Pain, Postoperative Clinical Trials

The Effect of Intraperitoneal Bupivacaine Versus Bupivacaine With Neostigmine on Pain in Laparoscopic Cholecystectomy

RCTcompstud
Start date: April 10, 2020
Phase: Phase 2
Study type: Interventional

Injection of intraperitoneal bupivacaine revealed an analgesic effect whether injected alone or in combination with other adjuvants, which increase duration of analgesia and decrease the dose of administered bupivacaine thus minimizing its side effects e.g. Opioids, Corticosteroids and Magnesium sulphate. Neostigmine, a cholinesterase inhibitor that produces muscarinic receptor-mediated analgesia, increased postoperative analgesia when combined with local anaesthetics. Peripheral afferent nerve fibres contain muscarinic receptors, these could be a good target for pain suppression.

NCT ID: NCT04285229 Completed - Spondyloarthritis Clinical Trials

A Study of Ixekizumab (LY2439821) in Chinese Participants With Radiographic Axial Spondyloarthritis

Start date: April 10, 2020
Phase: Phase 3
Study type: Interventional

The main purpose of this study is to evaluate the efficacy and safety of ixekizumab in Chinese participants with radiographic axial spondyloarthritis (r-axSpA).

NCT ID: NCT04316975 Completed - Clinical trials for Barretts Esophagus With Dysplasia

Utility Of Mutational Load As A Predictor For Endoscopic Treatment Response In Barrett's Esophagus

Start date: April 10, 2020
Phase: N/A
Study type: Interventional

To evaluate association between mutational load (ML) from esophageal biopsy specimens in pre-endoscopic eradication therapy (EET) in Barrett's Esophagus (BE) or Intramucosal adenocarcinoma (IMC) patients and treatment resistance (treatment resistance will be defined as disease recurrence and/or need for additional intervention such as increased acid suppression, need for anti-reflux surgery, or use of alternate ablative modality).

NCT ID: NCT04328987 Completed - Clinical trials for Post Polypectomy Bleeding

Safety of Cold Snare Polypectomy in Patients With Uninterrupted Antiplatelet Agent

Start date: April 10, 2020
Phase:
Study type: Observational

Polypectomy is regarded as high risk for bleeding. Several guidelines recommend continuous use of aspirin during polypectomy. However for clopidogrel, widely used antiplatelet agent, cessation of 5-7 is recommended. There is insufficient data regarding clopidogrel on post polypectomy bleeding. Delayed bleeding after polypectomy in patients with clopidogrel was reported as 3%. A recent study showed that delayed bleeding rate in patients with clopidogrel didn't differ that of who stopped clopidogrel. However the rate for delayed bleeding was 4%, higher than the previous studies. More studies are needed to conclude the safety of polypectomy in clopidogrel users. Cold snare polypectomy (CSP) can resect polyps without electrical energy. CSP are safe than conventional endoscopic mucosal resection in high risk for bleeding. The polypectomy techniques in most of studies were heterogenous, where delayed bleeding was investigated in clopidogrel users. There is no study to investigate safety of CSP in patients with clopidogrel users to date. The investigators hypothesized that the bleeding risk of CSP in patients with clopidogrel users would be similar to that of aspirin users. In this multicenter prospective study, the investigators aimed to compare the safety of CSP between aspirin and clopidogrel users.